Dr. Diomedes E. Logothetis leads a research lab focused on understanding and treating epilepsy and heart diseases, specifically through the study of ion channels, which are crucial for cell communication. The lab works on innovative therapies for Dravet Syndrome, a severe form of epilepsy in children, by investigating how activators of potassium channels can improve cellular function when sodium channels are impaired. Additionally, the lab aims to develop targeted drug therapies to address both atrial fibrillation and thrombosis by manipulating specific ion channels in the heart and blood platelets.

Dr. Ganesh A. Thakur's lab focuses on developing innovative treatments for chronic neuropathic pain without the addiction risks associated with opioids. The team investigates nicotinic acetylcholine receptors and cannabinoid receptors to create new non-addictive analgesics. By exploring small-molecule probes and their effects on pain pathways, the lab aims to improve pain management for millions suffering from chronic conditions.

Dr. Alexandros Makriyannis's lab at Northeastern University focuses on understanding the roles of cannabinoid receptors (CB1 and CB2) in treating various health conditions, particularly pain and inflammation. They design and develop innovative drug candidates that selectively modulate these receptors to create therapies with fewer side effects. The research not only explores the structure and function of these receptors but also aims to use this knowledge to identify new treatment options for diseases such as addiction and fibrotic disorders.